8-K - SELLAS Life Sciences Group, Inc. (0001390478) (Filer)
Published . Updated .
Key takeaways
- 8-K - SELLAS Life Sciences Group filed an 8-K with the SEC on Nov 17 (a notice of a material company event).
- Exposed: SLS
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - SELLAS Life Sciences Group filed an 8-K with the SEC on Nov 17 (a notice of a material company event).
Directly affected
- SLS SELLAS Life Sciences Group-30.3% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that SELLAS Life Sciences Group belongs to, so it often moves with news about it.
- LLY Eli Lilly and+25.1% 30d
Eli Lilly and is a peer of SELLAS Life Sciences Group in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson+12.1% 30d
Johnson & Johnson is a peer of SELLAS Life Sciences Group in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+12.0% 30d
AbbVie is a peer of SELLAS Life Sciences Group in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+3.5% 30d
Merck is a peer of SELLAS Life Sciences Group in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+10.0% 30d
Abbott Laboratories is a peer of SELLAS Life Sciences Group in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| SLS | +12.05% | +7.43% | base | after close | after close | after close | after close |
| XLV | +0.52% | -0.04% | base | after close | after close | after close | after close |
| LLY | -0.12% | -0.28% | base | after close | after close | after close | after close |
| JNJ | -0.65% | +0.33% | base | after close | after close | after close | after close |
| ABBV | -0.23% | -0.02% | base | after close | after close | after close | after close |
| MRK | +2.39% | +1.67% | base | after close | after close | after close | after close |
| ABT | +2.73% | -0.23% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-17 AccNo: 0001104659-26-128825 Size: 227 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
SELLAS Life Sciences Group (SLS) since “8-K - SELLAS Life Sciences Group, Inc. (0001390478) (Filer),” compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | three days earlier | -0.02% | final price |
| ABBV | five days earlier | -0.23% | final price |
| ABT | three days earlier | -0.23% | final price |
| ABT | five days earlier | +2.73% | final price |
| JNJ | three days earlier | +0.33% | final price |
| JNJ | five days earlier | -0.65% | final price |
| LLY | three days earlier | -0.28% | final price |
| LLY | five days earlier | -0.12% | final price |
| MRK | three days earlier | +1.67% | final price |
| MRK | five days earlier | +2.39% | final price |
| SELLAS Life Sciences Group (SLS) | three days earlier | +7.43% | final price |
| SELLAS Life Sciences Group (SLS) | five days earlier | +12.05% | final price |
| XLV | three days earlier | -0.04% | final price |
| XLV | five days earlier | +0.52% | final price |
Congressional trades in the stocks in this story
- Rep. David J. Taylor sold Eli Lilly (LLY), worth $1,001 - $15,000 on 3 Nov 2026. That is 14 days before publication. Filed 12 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 28 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 74 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 41 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 48 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 41 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 64 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 74 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 90 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Abbott Laboratories (ABT) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 41 days before publication. Filed 5 Nov 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - SELLAS Life Sciences Group, Inc. (0001390478) (Filer)”
Companies carried with this story
- SLS SELLAS Life Sciences Group
In “8-K - SELLAS Life Sciences Group, Inc. (0001390478) (Filer),” SELLAS Life Sciences Group (SLS) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> SLS
How “8-K - SELLAS Life Sciences Group, Inc. (0001390478) (Filer)” reaches SELLAS Life Sciences Group (SLS)
On 17 Nov 2026, “8-K - SELLAS Life Sciences Group, Inc. (0001390478) (Filer)” is the story that connects SELLAS Life Sciences Group (SLS) to this story.
The link for SELLAS Life Sciences Group (SLS) is this: SEC 8-K filing -> direct issuer disclosure -> SLS
Dates in the story, and the SELLAS Life Sciences Group (SLS) price range
SLS traded between 8.00 and 12.69 across 18 sessions. The latest close on file is 8.02.
How solid “8-K - SELLAS Life Sciences Group, Inc. (0001390478) (Filer)” looks
14 out of 100
“8-K - SELLAS Life Sciences Group, Inc. (0001390478) (Filer)” scores 14 out of 100. The score uses 1 source, and 1 linked company.